News
Rising viral load on dolutegravir? Investigators try fix before switch
- Author:
- Bianca Nogrady
“If you can get through those difficult phases, people can go back on their meds,” he said in an interview. “It’s almost a sociological problem...
News
Results from halted islatravir antiretroviral trial presented
- Author:
- Bianca Nogrady
Because of persistent concerns about the impact on CD4+ T cells and total lymphocytes, another phase 3 trial is now underway using a lower 0.25 mg...
News
Injecting long-acting antiretrovirals into clinic care
- Author:
- Bianca Nogrady
In the peer staff program, workers are trained in a 4-month medical residency–style program that shows them how to test for HIV, inject long-...
News
UNAIDS targets: Progress reported, but ‘HIV is far from over’
- Author:
- Bianca Nogrady
New infections persist at a rate that has not dropped as fast as possible.
News
Daily statin cuts cardiovascular risk in HIV
- Author:
- Bianca Nogrady
“These are types of people who, if they came to the doctor’s office right now before REPRIEVE, they would largely be told your risk score is not...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Patient selection key to lowering placebo response rates in lupus clinical trials
- Author:
- Bianca Nogrady
High placebo response rates in lupus clinical trials are making it difficult to show treatment effectiveness.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/July-2018/Furie_Richard_A_NY_web.jpg)
Strategies for complete B-cell depletion evolve for patients with lupus nephritis
- Author:
- Bianca Nogrady
Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/163571_Navarra_Sandra_web.jpg)
Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 results
- Author:
- Bianca Nogrady
Novel S1P1 receptor modulator cenerimod shows impact on disease activity in lupus, with more pronounced benefits in those with more severe disease...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/163550_Gladman_Dafna_web.jpg)
Early remission in lupus nephritis can still progress to advanced CKD
- Author:
- Bianca Nogrady
Patients with lupus nephritis who achieve complete remission within 1 year of starting treatment can still progress to advanced chronic kidney...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Fava_Andrea_MD_web.jpg)
Biomarkers for measuring lupus nephritis treatment response gain ground
- Author:
- Bianca Nogrady
A panel of protein biomarkers in urine could achieve better identification of lupus nephritis patients who are likely to respond to treatment.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/exercise_feet_running_web.jpg)
Running does not cause lasting cartilage damage
- Author:
- Bianca Nogrady
A single bout of running causes only transient and small changes to the thickness and structure of healthy cartilage in the knee.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Gossec_Laure_PARIS_2022_web.jpg)
Ustekinumab matches TNF inhibitors for psoriatic arthritis in 3-year, real-world study
- Author:
- Bianca Nogrady
A real-world study comparing the interleukin-12/23 inhibitor ustekinumab with tumor necrosis factor inhibitors for psoriatic arthritis found...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Dandrea_Elvira_MASS_web.jpg)
Hydroxychloroquine risk found in some older patients with RA
- Author:
- Bianca Nogrady
Hydroxychloroquine initiation in older patients with rheumatoid arthritis and a history of heart failure was associated with an increased risk of...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/May-2018/Smartphone_Apps_web.jpg)
Gout app improves treat to target, reduces flares
- Author:
- Bianca Nogrady
A smartphone app to help patients communicate their urate levels to clinicians means more achieve treatment targets and experience fewer flares....
News
No excess mortality seen in contemporary undifferentiated arthritis
- Author:
- Bianca Nogrady
Patients who meet the contemporary criteria for undifferentiated arthritis do not appear to have an increase in excess mortality, unlike those who...